Quick Takeaways
- Darwin Global Management, Ltd. filed SCHEDULE 13G for Belite Bio, Inc Ordinary Shares, par value US$0.0001 per share (BLTE).
- Disclosed ownership: 7%.
- Date of event: 03 Dec 2025.
Darwin Global Management, Ltd. - 03 Dec 2025 SCHEDULE 13G Report for Belite Bio, Inc Ordinary Shares, par value US$0.0001 per share (BLTE)
- Filing Manager
- Darwin Global Management, Ltd.
- Reporting Manager
- Darwin Global Management, Ltd.
- Symbol
- BLTE
- Shares outstanding
- 37,387,057 shares
- Disclosed Ownership
- 2,617,094 shares
- Ownership
- 7%
- Form type
- SCHEDULE 13G
- Filing time
- 10 Dec 2025, 16:30:21 UTC
- Date of event
- 03 Dec 2025
- Next filing
- 17 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Darwin Global Management, Ltd. disclosed 7% ownership in Belite Bio, Inc Ordinary Shares, par value US$0.0001 per share (BLTE) on 03 Dec 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 10 Dec 2025, 16:30.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Darwin Global Management, Ltd. | 7% | 2,617,094 | 0 | 2,617,094 | /s/ John Legge | John Legge, Director and Chief Financial Officer | |
| Dr. Abhishek Trehan | 7% | 2,617,094 | 0 | 2,617,094 | /s/ Dr. Abhishek Trehan | Dr. Abhishek Trehan, individually | |
| Darwin Global Master Fund, Ltd. | 6.7% | 2,527,589 | 0 | 2,527,589 | /s/ John Legge | By: Darwin Global Management, Ltd, its Investment Manager, By: John Legge, Director and Chief Financial Officer |